The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A rapid method for the isolation of functional thymus‐derived murine lymphocytes
Julius, M. H., Simpson, E., & Herzenberg, L. A. (1973) · European Journal of Immunology · doi:10.1002/eji.1830031011 · Cited by 4,147
Biology of the Mouse Histocompatibility-2 Complex
Klein, J. (1975) · Springer eBooks · doi:10.1007/978-3-642-48287-8 · Cited by 1,132
Zinkernagel, R. M., & Doherty, P. C. (1975) · The Journal of experimental medicine · doi:10.1084/jem.141.6.1427 · Cited by 628
Ozato, K., & Sachs, D. H. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.1.317 · Cited by 571
Schrier, P. I., Bernards, R., Vaessen, R. T. M. J., Houweling, A., & van der Eb, A. J. (1983) · Nature · doi:10.1038/305771a0 · Cited by 559
Protochordate allorecognition is controlled by a MHC-like gene system
Scofield, V. L., Schlumpberger, J. M., West, L. A., & Weissman, I. L. (1982) · Nature · doi:10.1038/295499a0 · Cited by 439
Wallich, R., Bulbuc, N., Hämmerling, G. J., Katzav, S., Segal, S., & Feldman, M. (1985) · Nature · doi:10.1038/315301a0 · Cited by 402
Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation
Hui, K., Grosveld, F., & Festenstein, H. (1984) · Nature · doi:10.1038/311750a0 · Cited by 341
PECULIAR IMMUNOBIOLOGY OF BONE MARROW ALLOGRAFTS
Cudkowicz, G., & Bennett, M. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.134.6.1513 · Cited by 340
Do Natural Killer Cells Engage in Regulated Reactions Against Self to Ensure Homeostasis?
Cudkowicz, G., & Hochman, P. S. (1979) · Immunological Reviews · doi:10.1111/j.1600-065x.1979.tb00266.x · Cited by 289
Cited by
Items 101–157 of 157
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants
Davies, S. M., Ruggieri, L., DeFor, T., Wagner, J. E., Weisdorf, D. J., Miller, J. S., Velardi, A., & Blazar, B. R. (2002) · Blood · doi:10.1182/blood-2002-04-1197 · Cited by 368
The Yin and Yang of HLA and KIR in human disease
Kulkarni, S., Martin, M. P., & Carrington, M. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.06.003 · Cited by 363
Yewdell, J. W., & Bennink, J. R. (1992) · Advances in Immunology · doi:10.1016/s0065-2776(08)60875-5 · Cited by 361
The Ets-1 Transcription Factor Is Required for the Development of Natural Killer Cells in Mice
Barton, K., Muthusamy, N., Fischer, C., Ting, C.-N., Walunas, T. L., Lanier, L. L., & Leiden, J. M. (1998) · Immunity · doi:10.1016/s1074-7613(00)80638-x · Cited by 359
Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection
Kelly, J. M., Darcy, P. K., Markby, J. L., Godfrey, D. I., Takeda, K., Yagita, H., & Smyth, M. J. (2002) · Nature Immunology · doi:10.1038/ni746 · Cited by 356
Bone marrow as a priming site for T-cell responses to blood-borne antigen
Feuerer, M., Beckhove, P., Garbi, N., Mahnke, Y., Limmer, A., Hommel, M., Hämmerling, G. J., Kyewski, B., Hamann, A., Umansky, V., et al. (2003) · Nature Medicine · doi:10.1038/nm914 · Cited by 353
NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.
Litwin, V, Gumperz, J., Parham, P., Phillips, J. H., & Lanier, L. L. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.537 · Cited by 348
Baginska, J., Viry, E., Berchem, G., Poli, A., Noman, M. Z., van Moer, K., Medves, S., Zimmer, J., Oudin, A., Niclou, S. P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304790110 · Cited by 344
Natarajan, K., Dimasi, N., Wang, J., Mariuzza, R. A., & Margulies, D. H. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064812 · Cited by 335
Carbone, E. (2005) · Blood · doi:10.1182/blood-2004-04-1422 · Cited by 333
NK Cells, MHC Class I Molecules and the Missing Self
Kärre, K. (2002) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2002.01053.x · Cited by 325
Self-citationYawata, M., Yawata, N., Draghi, M., Partheniou, F., Little, A.-M., & Parham, P. (2008) · Blood · doi:10.1182/blood-2008-03-143727 · Cited by 317
NK cells in HIV infection: Paradigm for protection or targets for ambush
Fauci, A. S., Mavilio, D., & Kottilil, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1711 · Cited by 306
Berg, M., Lundqvist, A., McCoy, P., Samsel, L., Fan, Y., Tawab, A., & Childs, R. (2009) · Cytotherapy · doi:10.1080/14653240902807034 · Cited by 304
Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes
Kast, W. M., Offringa, R., Peters, P. J., Voordouw, A. C., Meloen, R. H., van der Eb, A. J., & Melief, C. J. M. (1989) · Cell · doi:10.1016/0092-8674(89)90006-8 · Cited by 301
Wang, R., Jaw, J. J., Stutzman, N. C., Zou, Z., & Sun, P. D. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0611308 · Cited by 301
Natural killer cell-mediated immunosurveillance of human cancer
Malmberg, K.-J., Carlsten, M., Björklund, A., Sohlberg, E., Bryceson, Y. T., & Ljunggren, H.-G. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.002 · Cited by 299
Self-citationNatural killer cell recognition of missing self
Kärre, K. (2008) · Nature Immunology · doi:10.1038/ni0508-477 · Cited by 296
Self-citationCurrent Developments in Cancer Vaccines and Cellular Immunotherapy
Ribas, A., Butterfield, L. H., Glaspy, J. A., & Economou, J. S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.041 · Cited by 295
Perforin Is a Major Contributor to NK Cell Control of Tumor Metastasis
Smyth, M. J., Thia, K. Y. T., Cretney, E., Kelly, J. M., Snook, M. B., Forbes, C. A., & Scalzo, A. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6658 · Cited by 295
Ronchetti, A., Rovere, P., Iezzi, G., Galati, G., Heltai, S., Protti, M. P., Garancini, M. P., Manfredi, A. A., Rugarli, C., & Bellone, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.130 · Cited by 293
Signal Transduction during Natural Killer Cell Activation: Inside the Mind of a Killer
Leibson, P. J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80441-0 · Cited by 292
Joncker, N. T., Fernandez, N. C., Treiner, E., Vivier, E., & Raulet, D. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803900 · Cited by 291
NK cell education: not an on-off switch but a tunable rheostat
Brodin, P., Kärre, K., & Höglund, P. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.01.006 · Cited by 288
Self-citationA role for MHC class I molecules in synaptic plasticity and regeneration of neurons after axotomy
Oliveira, A. L. R., Thams, S., Lidman, O., Piehl, F., Hökfelt, T., Kärre, K., Lindå, H., & Cullheim, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408154101 · Cited by 286
Self-citationHam-2 corrects the class I antigen-processing defect in RMA-S cells
Attaya, M., Jameson, S., Martinez, C. K., Hermel, E., Aldrich, C., Forman, J., Lindahl, K. F., Bevan, M. J., & Monaco, J. J. (1992) · Nature · doi:10.1038/355647a0 · Cited by 285
Carlsten, M., Norell, H., Bryceson, Y. T., Poschke, I., Schedvins, K., Ljunggren, H.-G., Kiessling, R., & Malmberg, K.-J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901226 · Cited by 283
Self-citationVosshenrich, C. A. J., Ranson, T., Samson, S. I., Corcuff, E., Colucci, F., Rosmaraki, E. E., & Di Santo, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1213 · Cited by 283
Inhibitory MHC class I receptors on NK cells and T cells
Lanier, L. L., & Phillips, J. H. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80585-8 · Cited by 280
Tumor Eradication by Adoptive Transfer of Cytototic T Lymphocytes
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60294-8 · Cited by 275
Carayannopoulos, L. N., Naidenko, O. V., Fremont, D. H., & Yokoyama, W. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4079 · Cited by 274
Natural cytotoxicity receptors and their ligands
Kruse, P. H., Matta, J., Ugolini, S., & Vivier, E. (2014) · Immunology & Cell Biology · doi:10.1038/icb.2013.98 · Cited by 273
Höglund, P., Ohlén, C., Carbone, E., Franksson, L., Ljunggren, H. G., Latour, A., Koller, B., & Kärre, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10332 · Cited by 271
Self-citationNatural killer cells: In health and disease
Mandal, A., & Viswanathan, C. (2015) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2014.11.006 · Cited by 271
Iizuka, K., Naidenko, O. V., Plougastel, B. F. M., Fremont, D. H., & Yokoyama, W. M. (2003) · Nature Immunology · doi:10.1038/ni954 · Cited by 270
NK cells mediate clearance of CD8 + T cell–resistant tumors in response to STING agonists
Nicolai, C. J., Wolf, N., Chang, I.-C., Kirn, G., Marcus, A., Ndubaku, C. O., McWhirter, S. M., & Raulet, D. H. (2020) · Science Immunology · doi:10.1126/sciimmunol.aaz2738 · Cited by 268
The Killer Immunoglobulin-Like Receptor Gene Cluster: Tuning the Genome for Defense
Bashirova, A. A., Martin, M. P., McVicar, D. W., & Carrington, M. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115726 · Cited by 265
Human cytomegalovirus immunity and immune evasion
Jackson, S. E., Mason, G. M., & Wills, M. R. (2011) · Virus Research · doi:10.1016/j.virusres.2010.10.031 · Cited by 262
Ito, M., Maruyama, T., Saito, N., Koganei, S., Yamamoto, K., & Matsumoto, N. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051986 · Cited by 260
Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand
Tormo, J., Natarajan, K., Margulies, D. H., & Mariuzza, R. A. (1999) · Nature · doi:10.1038/45170 · Cited by 255
Sympathetic modulation of immunity: Relevance to disease
Bellinger, D. L., Millar, B. A., Perez, S., Carter, J., Wood, C., ThyagaRajan, S., Molinaro, C., Lubahn, C., & Lorton, D. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2007.09.005 · Cited by 254
c-myc down-regulates class I HLA expression in human melanomas.
Versteeg, R., Noordermeer, I. A., Krüse-Wolters, M., Ruiter, D. J., & Schrier, P. I. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02909.x · Cited by 252
Immunological Mechanisms Underneath the Efficacy of Cancer Therapy
Galluzzi, L., Zitvogel, L., & Kroemer, G. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0197 · Cited by 175
Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade
Torrejon, D. Y., Abril-Rodriguez, G., Champhekar, A. S., Tsoi, J., Campbell, K. M., Kalbasi, A., Parisi, G., Zaretsky, J. M., Garcia-Diaz, A., Puig-Saus, C., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1409 · Cited by 146
Kiessling, M. K., Klemke, C. D., Kamiński, M. M., Galani, I. E., Krammer, P. H., & Gülow, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3221 · Cited by 115
Miyake, T., Kumagai, Y., Kato, H., Guo, Z., Matsushita, K., Satoh, T., Kawagoe, T., Kumar, H., Jang, M. H., Kawai, T., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901500 · Cited by 115
Ly49 receptors: innate and adaptive immune paradigms
Rahim, M. M. A., Tu, M. M., Mahmoud, A. B., Wight, A., Abou-Samra, E., Lima, P. D. A., & Makrigiannis, A. P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00145 · Cited by 97
Aging, immune senescence, and immunotherapy: a comprehensive review
Elias, R., Hartshorn, K., Rahma, O., Lin, N., & Snyder-Cappione, J. E. (2018) · Seminars in Oncology · doi:10.1053/j.seminoncol.2018.08.006 · Cited by 96
Ichise, H., Nagano, S., Maeda, T., Miyazaki, M., Miyazaki, Y., Kojima, H., Yawata, N., Yawata, M., Tanaka, H., Saji, H., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.07.020 · Cited by 80
“Unique to NK cells is their ability to sense the lack of HLA class I expression on target cells: ‘‘missing self’’ (Joncker and Raulet, 2008; Kärre et al., 1986; Nakamura et al., 2013; Suzue et al., 2001; Velardi et al., 2009).”
BackgroundHealy, C., Munoz-Wolf, N., Strydom, J., Faherty, L., Williams, N. C., Kenny, S., Donnelly, S. C., & Cloonan, S. M. (2021) · Respiratory Research · doi:10.1186/s12931-021-01722-y · Cited by 78
The Host Defense Peptide Cathelicidin Is Required for NK Cell-Mediated Suppression of Tumor Growth
Büchau, A. S., Morizane, S., Trowbridge, J., Schauber, J., Kotol, P., Bui, J. D., & Gallo, R. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902110 · Cited by 73
Holmes, T. D., El-Sherbiny, Y. M., Davison, A., Clough, S. L., Blair, G. E., & Cook, G. P. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000951 · Cited by 52
Progress and challenges in developing allogeneic cell therapies
Deuse, T., & Schrepfer, S. (2025) · Cell Stem Cell · doi:10.1016/j.stem.2025.03.004 · Cited by 51
NK Cell–Specific CDK8 Deletion Enhances Antitumor Responses
Witalisz-Siepracka, A., Gotthardt, D., Prchal-Murphy, M., Didara, Z., Menzl, I., Prinz, D., Edlinger, L., Putz, E. M., & Sexl, V. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0183 · Cited by 47
Okita, R., Wolf, D., Yasuda, K., Maeda, A., Yukawa, T., Saisho, S., Shimizu, K., Yamaguchi, Y., Oka, M., Nakayama, E., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139809 · Cited by 39
Self-citationTGFβ in the obese liver mediates conversion of NK cells to a less cytotoxic ILC1-like phenotype
Cuff, A. O., Sillito, F., Dertschnig, S., Hall, A., Luong, T. V., Chakraverty, R., & Male, V. (2019) · doi:10.1101/576538 · Cited by 101
Hoerr, I. (2000) · doi:10.1002/1521-4141(200001)30:1
Metadata
- Authors
- Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R.
- Venue
- Nature
- Published
- 1986-02-20
- Volume
- 319
- Issue
- 6055
- Pages
- 675-678
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2088513299
- Cited by
- 2,161
- References
- 25
- FWCI
- 14.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.